Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
It will be interesting to see what happens over the coming days and weeks after todays announcement about Alzheimer's, I know many of us came onboard 5-6 years ago because of CDX and AML. Then there was a tranche of investors who came on because of Covid-19, but none of us are/were here because of progressive degrative brain diseases.... They are getting a very attractive entry point anyway for sure!
Nice name drop there, Penn hospital lined up, Biodefense... Still watching.... So far an excellent interview :-) Vlad is coming across very well in this interview and great to see Peter there too! Also already talking about IND enabling studies for CBR this year.
One criticism for both parties? Move the camera close to the screen please next time your looking wayyyy off from the audience :P And Peter put laptop on a table!
Ok finished, finally Vlad has broken the seal and started talking, updates starting to come and very promising year ahead!
Its here: https://www.londonstockexchange.com/news-article/HEMO/cbr-brain-delivery/16335503
At some point it should land on LSE with a red dot which will trigger notifications for lots more traders via this site. I also fully expect that Vlad will have to break his silence soon with some sort of interview or statement on direction of the company, but given the recent updates he deserves a break for not having done one already, he really has been busy!
MrI, are you SERIOUSLY using that term on here? Dont even start equating what Hemogenyx has delivered in recent days to what AIM directors do day in day out promising gold and diamonds in interview after interview only to do a monthly multi million raise to fund their lifestyle.
Ofcourse Hemogenyx need cash, and ofcourse they have likely lined up a cash investment with Prevail at 6p as I have been saying for months. AND THEY BLOODYWELL DESERVE TO DO SO. What exactly is the problem with that? People should be nervous because if the SP rises above 6p Prevail might make another strategic long term investment helping Hemogenyx continue research in multiple directions AND start clinical trials?
Would argue its the inverse of that, both recent updates, are so significant for a company with such a low mCap that they should not have waited to RNS. Had there been no clinical hold applied by the FDA I am sure both of these updates would have been released long ago as alluded too by the video showing Vlads presentation. Theses are ground breaking advancements with wide ranging implications not just in Cancer where focus has been for the past 6 years.
The Clinical Hold meant Vlad dedicated every spare ounce he had to getting that hold lifted, now it is? Prevail will take over and you can be sure of an update on that in the coming days or weeks. Vlad now will turn his focus to the gem of Hemogneyx, CBR.
Https://www.alz.org/alzheimers-dementia/what-is-alzheimers/brain_tour_part_2
Worth reading the damage that plaques can cause to the brain and the link to alzheimers, if CBR really can target and remove these plaques then the potential to save lives is absolutely huge and ANYONE shorting or attacking Hemogenyx really needs to stop, think and move on. I have one grandmother in a home who has no clue who I am and a mother heading in that direction because of this disgusting disease. I hope to god Vlad makes this a priority and it works and he gets some serious help to move this along as quickly as humanly possible.
Spot in HH, big question, how many shares did he have? His MO is load up on cheap, wait for rns, dump, deramp and repeat. Vlad might just have caught him out for once!
Had alot of people selling off the back of ind who ONLY bought to sell. People assume it will happen again now? Did traders have time to buy in low again? Doubt it but time will tell :-)
The shorters had made it up to 10% yesterday on ig, could be fireworks.
Vlad put everything on hold for CAR-T, the Cork is popped and vlad now has time to deliver!
Good job Vlad, very good job, this really could destroy those traders today, absolutely fantastic. Proves everything was waiting for hemogenyx to go clinical.
I actually predicted your return today earlier on when it was obvious the blocks had stopped. Now to check for the obligatory troll tweets 🤣😂🤣
HH, Pingu, India etc, I told you he would pop up!!! Lol! Called it, so loaded up pre approval and has finished dumping, excellent!
New account, going hell for leather 19 posts in 24 hrs, no effort to hide motives or build any sort of profile first..... someone is getting desperate, 10% short on IG, what's that? About 8-10 million short shares?
Knowing that the next update is likely launch of trials or maybe PR/Interviews kicking off new buying. Must be uncomfortable.... for me I will wait, found a Spreadbet earlier when chatting to MrI, opened at like 10k a point at 1.24p like a year ago lol. For some of us waiting is nothing new and not a reason to be nervous. If your short..... Good luck!
Lol, I wonder who could it be? need to do some thinking, someone who was banned now posting obsessed with hemogenyx, need to think, but 1 and 1 together and see what I come up with :P
Haywain, are you on twitter? would love to chat some time
You do get that Hemogenyx has been well over 6p EVEN if you factor in dilution? It was quite stable 10p for a very long time before the Mint fiasco. At a time where Hemogenyx had NOTHING clinical? When CBR was still a secret and CAR-T was only in IND enabling studies? Have you any idea what Hemogenyx do or what the value of pharma is? Another pumpkin perhaps who have stumbled across a ticker and literally know nothing about the company behind it :P
Come on must be some actual Pharma investors out there lol!!!
Davie..... Well over half the population would disagree with you on that final point.... :-D However your point is well made, Mickey? I fundamentally disagree with his view and outlook but he is basing it on past experience and he is frustrated like us all. None of us can deny frustration and having a contrary viewpoint is not a bad thing. Pumpkin? Its negativity for the point of negativity. It was notable that she did not post atall last week in the lead up to the IND approval or immediately after, its only when the SP dropped back and some negativity returned that pumpkin returned. There are some posters that only appear when the SP is going up and some that only appear when its going or is down. Just shows complete lack of backbone to refuse to post when company is up and doing well lest she be called out for the preceding negativity :P
Despite what some may think, 30mil valuation for Hemogenyx is NOT realistic.
HEMO-CAR-T have just had approval to enter clinical trials, CAR-T treatments in recent years have been licenced at pre clinical, phase 1, phase 2/3 and after new drug approval. Prices for these licencing agreements are freely available, the vast majority, INCLUDING phase 1 etc, are 500m+ when you include milestone payments. HEMO-CAR-T today with the IND approval is worth easily multiples of the current mCap of Hemogenyx, when trials start IF it works the value becomes multiples and will be known within the first few patients/months.
CDX - basically this is same target market as #AVCT are aiming for, expanding chemo to many more people and reducing the toxic side effects. They want to make Chemo safer, CDX removes chemo altogether but gives same targeted results, Avct have targeted the value at billions? Same applies here, only CDX is better and because its not making EXISTING chemo safer where any revenue would be split, CDX is 100% hemogenyx (Eli Lilly will get some profits from this)
CBR - https://bnnbreaking.com/breaking-news/health/groundbreaking-mrna-therapeutics-breakthrough-room-temperature-stable-treatments-for-global-accessibility I think that makes it clear that even just the approach they have taken makes CBR as an idea worth billions, take the patented CBRs for each virus they can treat? There is no valuation high enough to cover every possibility. Will we ever see true value before its taken out of our hands? Probably not, but I can guarantee you £30m does not even scratch the surface.
100-300m valuation for a CLINICAL pharma with ANY ONE of the above would be cheap, https://sana.com/our-pipeline/ have literally an equivalent to HEMO-CAR-T and they are worth 1.55 BILLION. This current SP/mCap is just stupid, low visibility, lot of traders/shorters and lots of efforts to push the SP over the last week has successfully pushed the SP back down to a stupid price. BUT the shorters cant stay open for ever IG shows 8%, thats alot of shares that need to be bought back to close those positions, This valuation IS WRONG. The current market Valuation IS WRONG. Tick Tock, the rest of the world SLOWLY are starting to notice Hemogenyx, this will only increase as they enter Clinical Trials.